Diabetes type2 - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance occurs when cells in muscles, fat, and the liver do not respond well to insulin, leading to impaired glucose uptake and increased blood sugar levels. This is often associated with obesity and physical inactivity, which exacerbate the resistance.

• Secondary mechanism: Beta-cell dysfunction in the pancreas results in inadequate insulin secretion over time. The pancreas initially compensates for insulin resistance by producing more insulin, but eventually, the beta cells become exhausted and fail to maintain necessary insulin levels.

• Key complication: Chronic hyperglycemia leads to microvascular and macrovascular complications, such as neuropathy, retinopathy, and cardiovascular disease, posing significant long-term health risks and requiring diligent management to prevent progression.

Patient Profile

Demographics:

58-year-old male, office manager

History:

• Key past medical history: Diagnosed with Type 2 Diabetes 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 40 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and tingling sensation in feet

• Key symptoms: Blurred vision, frequent urination, increased thirst, numbness in lower extremities

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 88 bpm, Respiratory rate 18 breaths per minute, Temperature 98.6°F, BMI 31 kg/m²

Section 1

New Diagnostic Results:

The initial assessment indicates that the patient's symptoms and elevated blood pressure suggest poor glycemic control and possible progression of diabetic complications. Laboratory tests are ordered to gain a clearer understanding of the patient's current status. The results reveal a Hemoglobin A1c level of 9.2%, indicating sustained hyperglycemia over the past three months. Fasting blood glucose is measured at 178 mg/dL, further confirming inadequate control of blood glucose levels. Additionally, lipid profile results show elevated LDL cholesterol at 160 mg/dL and triglycerides at 220 mg/dL, while HDL cholesterol remains low at 35 mg/dL. These findings suggest that the patient is at increased risk for cardiovascular disease due to the combination of hyperlipidemia and poorly controlled diabetes.

Urinalysis reveals microalbuminuria, suggesting early signs of diabetic nephropathy, a microvascular complication of diabetes. This finding necessitates a more aggressive approach to manage both blood glucose levels and hypertension to prevent further kidney damage. An ophthalmology referral is made to evaluate the blurred vision, suspecting diabetic retinopathy, another common microvascular complication. The patient's complaint of tingling and numbness in the feet raises concern for peripheral neuropathy, requiring a comprehensive neurological examination and possible referral to a specialist for further evaluation.

These diagnostic results highlight the need for an urgent reevaluation of the patient's current management plan. The healthcare team discusses potential adjustments in medication, such as intensifying the current diabetes regimen with the addition of a GLP-1 receptor agonist or SGLT2 inhibitor, which could help address both glycemic control and reduce cardiovascular risk. Furthermore, lifestyle modifications, including dietary changes and increased physical activity, are emphasized to mitigate insulin resistance and improve the patient's overall health. The team recognizes the importance of collaborating with a multidisciplinary team, including a dietitian and diabetes educator, to optimize the patient's care and prevent further complications.

Section 2

A few weeks after implementing the revised management plan, the patient returns for a follow-up appointment. During this visit, the healthcare team conducts an evaluation to assess the response to the interventions. The patient reports a modest improvement in energy levels and a slight reduction in the frequency of numbness in their feet. However, they continue to experience blurred vision intermittently. The physical examination reveals that the blood pressure has improved slightly to 140/85 mmHg, but it remains above the target of less than 130/80 mmHg. Importantly, the patient's weight has decreased by 4 pounds, reflecting adherence to dietary changes and increased physical activity.

Repeat laboratory tests show a reduction in fasting blood glucose to 150 mg/dL, suggesting some improvement in glycemic control. However, the Hemoglobin A1c remains elevated at 8.7%, indicating a need for further optimization of the diabetes management regimen. The lipid profile has shown slight improvement, with LDL cholesterol reduced to 145 mg/dL and triglycerides to 190 mg/dL, though HDL cholesterol remains low at 37 mg/dL. The presence of microalbuminuria persists, reinforcing the need to intensify efforts to protect renal function.

Given these findings, the healthcare team decides to adjust the patient's medication regimen further. A decision is made to add an SGLT2 inhibitor, which offers benefits for both blood glucose management and renal protection. Additionally, the team emphasizes the importance of continued lifestyle modifications and schedules regular follow-up appointments to monitor progress. The patient is referred to a podiatrist for a comprehensive foot examination to further evaluate the peripheral neuropathy and prevent potential complications. As the patient continues on this journey, the healthcare team remains committed to proactive monitoring and adjustments to achieve optimal outcomes and prevent the progression of diabetes-related complications.

Section 3

A month later, the patient returns for another follow-up appointment. During the visit, the healthcare team notes that the patient has experienced further improvement in energy levels and a reduction in the frequency of blurred vision episodes. The patient reports that the numbness in their feet has decreased significantly since starting the SGLT2 inhibitor. On physical examination, the blood pressure has improved to 135/80 mmHg, closer to the target goal. The patient has lost an additional 3 pounds, indicating continued adherence to lifestyle modifications.

New diagnostic results show a further reduction in fasting blood glucose to 130 mg/dL, and the Hemoglobin A1c has decreased to 8.1%, showing a positive trend but still requiring attention. The lipid profile has also improved, with LDL cholesterol now at 135 mg/dL and triglycerides at 170 mg/dL. However, HDL cholesterol remains unchanged at 37 mg/dL. Microalbuminuria persists, though with a slight reduction in levels, indicating a potential benefit from the SGLT2 inhibitor's renal protective effects. The podiatrist's report confirms the presence of peripheral neuropathy but notes no significant ulceration or deformities, which is reassuring.

Despite these improvements, the patient's intermittent blurred vision raises concerns about possible diabetic retinopathy. The healthcare team decides to refer the patient to an ophthalmologist for a comprehensive eye examination. This step is crucial to detect any retinal changes early and to implement appropriate interventions if necessary. The team also emphasizes the importance of maintaining regular follow-ups, continuing medication adherence, and making further dietary adjustments to support ongoing improvements in blood glucose and lipid levels. The patient's case demonstrates the interconnected nature of diabetes management, highlighting the need for a multidisciplinary approach to address the complexities of the condition and prevent further complications.

Section 4

A few weeks after the ophthalmology referral, the patient returns for a follow-up visit with the healthcare team. The ophthalmologist's report confirms the presence of mild non-proliferative diabetic retinopathy. This finding underscores the importance of tight glycemic and blood pressure control to prevent further progression of the condition. During the current visit, the patient reports being more vigilant with their dietary choices and maintaining regular physical activity, which has contributed to a slight additional weight loss, now totaling 5 pounds since the initial visit.

New diagnostic results indicate a fasting blood glucose level of 125 mg/dL and a further reduction in Hemoglobin A1c to 7.8%. While this progress is encouraging, the healthcare team recognizes the need to address the persistent issue of low HDL cholesterol, which remains at 37 mg/dL. To improve the patient's lipid profile, the team considers the introduction of a statin, given the patient's high cardiovascular risk associated with diabetes. Blood pressure remains stable at 130/78 mmHg, and microalbuminuria shows further reduction, reinforcing the renal benefits of the SGLT2 inhibitor.

Despite these positive developments, the patient raises a new concern about occasional episodes of dizziness and lightheadedness, particularly when standing up quickly. This prompts the healthcare team to evaluate for potential orthostatic hypotension, possibly as a side effect of medication adjustments or dehydration. A thorough assessment, including orthostatic blood pressure measurements, reveals a significant drop in blood pressure upon standing. The team decides to adjust the patient's medication regimen to address this issue while ensuring continued management of diabetes and its complications. This situation highlights the delicate balance required in diabetes care, emphasizing the need for ongoing monitoring and individualized treatment plans.

Section 5

During the follow-up visit, the healthcare team conducts a detailed assessment to further investigate the patient's complaint of dizziness and lightheadedness. The initial assessment findings reveal that the patient experiences these symptoms predominantly in the morning and after prolonged periods of sitting or lying down. Upon standing, the patient's blood pressure drops from 130/78 mmHg to 100/65 mmHg, confirming the presence of orthostatic hypotension. Additionally, the patient reports feeling fatigued and notes a mild increase in thirst, which could suggest dehydration or inadequate fluid intake. The patient's heart rate increases from 72 to 88 beats per minute upon standing, indicating a compensatory response to the blood pressure drop.

The healthcare team decides to adjust the patient's medication regimen, suspecting that the combination of the SGLT2 inhibitor and other antihypertensive agents may be contributing to the orthostatic hypotension. They opt to reduce the dose of the diuretic while encouraging the patient to increase fluid intake gradually. The team also educates the patient on lifestyle modifications, such as rising slowly from sitting or lying positions and monitoring fluid balance, to minimize the risk of dizziness and prevent falls. The patient is advised to keep a symptom diary to track episodes of dizziness and any potential triggers, which will be reviewed in the next appointment.

These interventions aim to stabilize the patient's symptoms while maintaining effective control of diabetes and blood pressure. The healthcare team emphasizes the importance of continued monitoring of the patient's cardiovascular risk factors, especially given the recent introduction of a statin to address low HDL cholesterol levels. They schedule a follow-up appointment in two weeks to reassess the patient's response to the medication adjustments and to ensure that glycemic and blood pressure control remain optimal. This ongoing process highlights the need for a dynamic and individualized approach in managing diabetes and its complications, ensuring that treatment plans evolve in response to the patient's changing clinical status.